Medical Ikkou Group Co.,Ltd. Share Price

Equities

3353

JP3921040006

Drug Retailers

Market Closed - Japan Exchange 06:15:41 01/05/2024 am IST 5-day change 1st Jan Change
2,553 JPY -0.04% Intraday chart for Medical Ikkou Group Co.,Ltd. +3.82% +23.75%

Financials

Sales 2022 33.6B 217M 18.06B Sales 2023 33.9B 219M 18.22B Capitalization 9.73B 62.73M 5.23B
Net income 2022 852M 5.49M 458M Net income 2023 759M 4.89M 408M EV / Sales 2022 0.38 x
Net Debt 2022 3.32B 21.4M 1.78B Net Debt 2023 2.67B 17.23M 1.44B EV / Sales 2023 0.37 x
P/E ratio 2022
11.2 x
P/E ratio 2023
12.8 x
Employees 1,297
Yield 2022
1.57%
Yield 2023
1.54%
Free-Float 25.99%
More Fundamentals * Assessed data
Dynamic Chart
Medical Ikkou Group Co.,Ltd. agreed to acquire Okinawa Amel Co., Ltd. from Seibu Sawai Yakuhin K.K. CI
Medical Ikkou Group Co.,Ltd. entered into basic agreement to acquire 50% stake in Hakuai Nakai Ethical Pharmacy Co., Ltd. from Kanichi Eguchi. CI
Medical Ikkou Group Co.,Ltd. Reports Earnings Results for the Full Year Ended February 28, 2023 CI
Tranche Update on Medical Ikkou Group Co.,Ltd.'s Equity Buyback Plan announced on June 17, 2020. CI
Medical Ikkou Group Co.,Ltd.'s Equity Buyback announced on June 17, 2020 has expired with 30,900 shares for ¥271.92 million. CI
An unknown buyer acquired an unknown stake in Qol Holdings Co., Ltd. from Medical Ikkou Group Co.,Ltd.. CI
Medical Ikkou Group Co.,Ltd. announces an Equity Buyback for 40,000 shares, representing 2.1% for ¥352 million. CI
Medical Ikkou Group Co.,Ltd. authorizes a Buyback Plan. CI
Medical Ikkou Co., Ltd. cancelled the acquisition of Efa Co., Ltd from Nakagawa Sangyo Co.,Ltd and Takashi Nakagawa. CI
Tranche Update on Medical Ikkou Co., Ltd.'s Equity Buyback Plan announced on November 21, 2018. CI
Medical Ikkou Co., Ltd.'s Equity Buyback announced on November 21, 2018 has expired with 9,900 shares for ¥80.69 million. CI
Medical Ikkou Co., Ltd. announces an Equity Buyback for 15,000 shares, representing 0.78% for ¥122.25 million. CI
Medical Ikkou Co., Ltd. authorizes a Buyback Plan. CI
Medical Ikkou Co., Ltd. agreed to acquire Efa Co., Ltd from Nakagawa Sangyo Co.,Ltd and Takashi Nakagawa. CI
Medical Ikkou Co., Ltd. cancelled the acquisition to acquire Taiho Yakuhin Co., Ltd. from Seiichi Asai. CI
More news
1 day-0.04%
1 week+3.82%
Current month+6.51%
1 month+3.11%
3 months+12.96%
6 months+19.41%
Current year+23.75%
More quotes
1 week
2 450.00
Extreme 2450
2 580.00
1 month
2 400.00
Extreme 2400
2 904.00
Current year
2 063.00
Extreme 2063
2 904.00
1 year
2 025.00
Extreme 2025
2 904.00
3 years
2 025.00
Extreme 2025
3 000.00
5 years
2 025.00
Extreme 2025
4 670.00
10 years
1 358.50
Extreme 1358.5
9 900.00
More quotes
Managers TitleAgeSince
Founder 67 17/85/17
Director of Finance/CFO 70 01/05/01
Chief Administrative Officer - -
Members of the board TitleAgeSince
Founder 67 17/85/17
Corporate Officer/Principal 63 01/91/01
Director of Finance/CFO 70 01/05/01
More insiders
Date Price Change Volume
01/24/01 2,553 -0.04% 800
30/24/30 2,554 +2.36% 2,500
26/24/26 2,495 +0.81% 700
24/24/24 2,475 +0.65% 1,100
23/24/23 2,459 +0.33% 200

Delayed Quote Japan Exchange, May 01, 2024 at 06:15 am IST

More quotes
Medical Ikkou Group Co.,Ltd. is a Japan-based company mainly engaged in the operation of dispensing pharmacies that fill prescriptions for general patients based on the medical prescriptions issued by medical institutions. The Company operates in four business segments. The Dispensing Pharmacy segment is specialized in the sale of medical drugs based on medical prescriptions. The Healthcare segment is engaged in the operation of nursing care facilities, the leasing of medical facilities and others, as well as the medical care and nursing care related businesses. The Medicine Wholesale segment is engaged in the sale of pharmaceutical products to medical institutions and others. The Real Estate segment is engaged in the leasing of real estate properties.
More about the company